logo
Plus   Neg
Share
Email

Apple's SVP Of Hardware Engineering Transitions To Unspecified Project

Apple Inc. (AAPL) Monday announced that Dan Riccio, current SVP of hardware engineering, is transitioning to a new role where he will focus on an unspecified project. John Ternus will succeed Riccio as Apple's SVP of hardware engineering.

Riccio will be reporting to CEO Tim Cook. However, the tech giant did not disclose any details about what project Riccio will be working on, but Apple has an Apple Car and various augmented reality and virtual reality devices in the works.

"Every innovation Dan has helped Apple bring to life has made us a better and more innovative company, and we're thrilled that he'll continue to be part of the team," said Tim Cook, Apple's CEO. "John's deep expertise and wide breadth of experience make him a bold and visionary leader of our Hardware Engineering teams. I want to congratulate them both on these exciting new steps, and I'm looking forward to many more innovations they'll help bring to the world."

Ternus takes on the role of senior vice president of Hardware Engineering. Ternus joined Apple's Product Design team in 2001 and has been a vice president of Hardware Engineering since 2013.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Mediterranean Food Inc is recalling its "Alqosh Sesame Oil" citing the potential to be contaminated with Salmonella, the U.S. Food and Drug Administration said. The affected Alqosh Sesame Oil "Tahin" comes in a 2Lb, clear plastic jar marked with lot # 16082020 on the side of the jar and with a Production date of 08/16/2020 stamped on the side. Twitter has filed a lawsuit against Texas Attorney General Ken Paxton, seeking to halt his ongoing investigation into the company's content moderation practices. Paxton, a Republican and supporter of former president Donald Trump, on January 13 had sent a civil investigative demand or CID to Twitter after its decision to permanently suspend Trump from the social media platform... The U.S. Food and Drug Administration granted emergency use authorization (EUA) for the first and only clinical T cell-based test for patients to detect the unique T-cell signature specific to SARS-CoV-2, the virus that causes COVID-19. The test confirms recent or prior COVID-19 infection. Developed by Adaptive Biotechnologies, T-Detect COVID Test is a next generation sequencing based (NGS) test.
Follow RTT